C, 83.60; H, 8.37; N, 3.75. Found: C, 83.78; H, 8.17; N, 3.70. By
In summary, total syntheses of enantiopure alkaloidal
natural products (2S,6R)-dihydropinidine (7a, as hydro-
chloride) and (2S,6R)-isosolenopsins (7b-e, as hydro-
chlorides) were achieved with the shortest steps and
unprecedented high total yields by using a strategy of
the formation-cleavage of 1,3-oxazinane. (S)-Betti base
[(S)-3] was proved to be an excellent chiral auxiliary and
its naphthol moiety played an important role in diste-
reoselectivity and reactivity. Thus, (S)-3 condensed with
pentane-1,5-dial and benzotriazole to diastereopurely
yield 4 in 92% yield. By using THF as solvent, a solvent-
controlled monoalkylation of 4 was achieved to give
diastereopure 5 in 96% yield. Then 5 was alkylated with
the corresponding Grignard reagent followed by a novel
N-debenzylation straightforward to amine hydrochloride
by Pd/C-catalyzed hydrogenolysis in the presence of
CH2Cl2 to yield target products 7a-e in 90-93% yields
(two steps), respectively.
the exact same procedure, compounds 6b-e were prepared by
using other Grignard reagents (RMgBr, R ) -C9H19, -C11H23
,
-C13H27, -C15H31, respectively), which were used to the next
step without further purification.
A Typical Procedure for the Preparation of (2S,6R)-2-
Methyl-6-propylpiperidine Hydrochloride [7a‚HCl, (2S,6R)-
Dihydropinidine Hydrochloride]. A mixture of compound 6a
(560 mg, 1.5 mmol), 10% Pd-C catalyst (160 mg, 0.15 mmol) in
MeOH (20 mL), and CH2Cl2 (10 mL) under H2 was stirred at
room temperature and atmospheric pressure until the absorption
of hydrogen ceased. After the catalyst was filtered out, the
filtrate was evaporated and Et2O (20 mL) was added. The
desired product 7a‚HCl as white crystals was collected by
filtration. Mp 240-242 °C (MeOH); [R]25 -13.2 (c 0.2, EtOH)
D
[lit.3e mp 242-243 °C, [R]25 -13.3 (c 1.0, EtOH)]. IR: ν 2955,
D
1
2935, 1459, 1380 cm-1. H NMR: δ 9.41 (br s, 1H), 9.07 (br s,
1H), 3.15-2.98 (m, 1H), 2.98-2.81 (m, 1H), 2.18-1.43 (m, 10H),
1.43-1.10 (m, 3H), 0.90 (t, J1 ) 7.2 Hz, 3H). 13C NMR: δ 58.4,
54.5, 35.1, 30.7, 27.4, 22.8, 19.4, 18.8, 13.7. Anal. Calcd for
C9H19N‚HCl: C, 60.83; H, 11.34; N, 7.88. Found: C, 60.87; H,
11.43; N, 7.76.
(2S,6R)-2-Methyl-6-nonylpiperidine Hydrochloride [7b‚
HCl, (2S,6R)-Isosolenopsin Hydrochloride]. Mp 176-177
°C; [R]25D -12.5 (c 0.2, CHCl3) [lit.3d as an enantiomeric isomer,
mp 174-175 °C, [R]25D +11.1 (c 0.92, CHCl3)]. IR: ν 2924, 2853,
Experimental Section
(7aR,11R,13S)-11-(1H-Benzotriazol-1-yl)-7a,8,10,11-tet-
rahydro-13-phenyl-9H,13H-naphtho[1,2-e]pyrido[2,1-b][1,3]-
oxazine (4). To a stirred solution of (S)-3 (as a salt of L-(+)-
tartaric acid, 11.97 g, 30 mmol) and benzotriazole (4.29 g, 36
mmol) in CH2Cl2 (120 mL) was added dropwise pentane-1,5-dial
(25% aqueous solution, 14.40 g, 36 mmol) at 0 °C under nitrogen.
Then K2CO3 powder was added to adjust the pH to 8-9. Twenty
minutes later (monitored by TLC), an aqueous solution of NaOH
(1.0 M, 60 mL) was added and stirring was continued for another
15 min. Then resultant mixture was filtered through a pad of
Celite. The filtrate was washed with H2O and brine and dried
over anhydrous Mg2SO4. After the removal of the solvent, the
residue was purified by recrystallization to give the desired
product 4 (11.92 g, 92%) as a colorless crystal, mp 180-182 °C
1465, 1380 cm-1 1H NMR: δ 9.45 (br s, 1H), 9.07 (br s, 1H),
.
3.13-2.98 (m, 1H), 2.98-2.80 (m, 1H), 2.20-1.50 (m, 10H),
1.50-1.10 (m, 15H), 0.86 (t, J1 ) 6.6 Hz, 3H). 13C NMR: δ 58.6,
54.5, 33.2, 31.8, 30.7, 29.6, 29.5, 29.3, 29.2, 27.4, 25.7, 22.9, 22.6,
19.4, 14.0. Anal. Calcd for C15H31N‚HCl: C, 68.80; H, 12.32; N,
5.35. Found: C, 68.96; H, 12.46; N, 5.42.
(2S,6R)-2-Methyl-6-decanylpiperidine Hydrochloride [7c‚
HCl, (2S,6R)-Isosolenopsin A Hydrochloride]. Mp 147-148
°C; [R]25D -9.9 (c 0.2, CHCl3) [lit.12 [R]20D -10.3 (c 1.3, CHCl3)].
1
IR: ν 2921, 2852, 1383 cm-1. H NMR: δ 9.43 (br s, 1H), 9.06
(br s, 1H), 3.13-2.96 (m, 1H), 2.96-2.80 (m, 1H), 2.20-1.48 (m,
10H), 1.48-1.10 (m, 19H), 0.86 (t, J1 ) 6.5 Hz, 3H). 13C NMR:
δ 58.6, 54.5, 33.2, 31.8, 30.7, 29.6 (3C), 29.5, 29.3, 29.2, 27.4,
25.6, 22.8, 22.6, 19.4, 14.1. Anal. Calcd for C17H35N‚HCl: C,
70.43; H, 12.52; N, 4.83. Found: C, 70.44; H, 12.46; N, 4.80.
(2S,6R)-2-Methyl-6-tridecanylpiperidine Hydrochloride
[7d‚HCl, (2S,6R)-Isosolenopsin B Hydrochloride]. Mp 140-
(CH2Cl2/CH3OH), [R]25 +164.8 (c 0.2, CHCl3) [lit.8e mp 196-
D
197 °C (EtOH), [R]25 +152.6 (c 1.6, CHCl3)].
D
(7aR,11S,13S)-7a,8,10,11-Tetrahydro-11-methyl-13-phen-
yl-9H,13H-naphtho[1,2-e]pyrido[2,1-b][1,3]oxazine (5). To
a cold solution (ice-water bath) of 4 (12.96 g, 30 mmol) in dry
THF (200 mL) was added MeMgCl (3.0 M in THF, 24 mL, 72
mmol) dropwise under nitrogen. After the reaction was stirred
at 0 °C for 2.0 h (monitored by TLC), a saturated aqueous
solution of NH4Cl (50 mL) was added to quench the reaction.
Then the resultant mixture was extracted with CH2Cl2. The
combined organic layers were washed with H2O and brine and
dried over anhydrous Mg2SO4. After the removal of the solvent,
the residue was purified by chromatography (silica gel, EtOAc:
PE ) 1:15) to give the desired product 5 (9.48 g, 96%) as a
142 °C; [R]25 -9.4 (c 0.2, CHCl3) [lit.3d as an enantiomeric
D
isomer, mp 145-146 °C, [R]25D +8.5 (c 1.0, CHCl3)]. IR: ν 2919,
1
2851, 1591, 1465, 1385 cm-1. H NMR: δ 9.43 (br s, 1H), 9.07
(br s, 1H), 3.13-2.97 (m, 1H), 2.97-2.80 (m, 1H), 2.20-1.49 (m,
10H), 1.49-1.10 (m, 23H), 0.86 (t, J1 ) 6.6 Hz, 3H). 13C NMR:
δ 58.6, 54.5, 33.2, 31.9, 30.7, 29.6, 29.5, 29.3, 29.2, 27.4, 25.7,
22.9, 22.6, 19.4, 14.0. Calcd for C19H39N.HCl: C, 71.77; H, 12.68;
N, 4.40. Found: C, 71.60; H, 12.48; N, 4.41.
(2S,6R)-2-Methyl-6-pentadecanylpiperidine Hydrochlo-
ride [7e‚HCl, (2S,6R)-Isosolenopsin C Hydrochloride]. Mp
137-139 °C; [R]25D -8.0 (c 0.2, CHCl3) [lit.3d as an enantiomeric
isomer, mp 140-141 °C, [R]25D +8.2 (c 1.0, CHCl3)]. IR: ν 2919,
2850, 1591, 1465, 1441, 1385 cm-1. 1H NMR: δ 9.41 (br s, 1H),
9.05 (br s, 1H), 3.12-2.98 (m, 1H), 2.98-2.80 (m, 1H), 2.20-
1.45 (m, 10H), 1.45-1.10 (m, 27H), 0.86 (t, J1 ) 6.3 Hz, 3H).
13C NMR: δ 58.5, 54.4, 33.2, 31.8, 30.6, 29.6 (7C), 29.5, 29.3,
29.2, 27.4, 25.6, 22.8, 22.6, 19.4, 14.0. Calcd for C21H43N‚HCl:
C, 72.89; H, 12.82; N, 4.05. Found: C, 72.83; H, 12.66; N, 4.08.
Products 7f-j‚HCl were prepared by the exact same proce-
dure and have identical physical data as reported in published
literature.
colorless crystal, mp 120-122 °C. [R]25 +161.6 (c 0.2, CHCl3).
D
IR: ν 2935, 1624, 1515, 1465 cm-1. H NMR: δ 7.06-7.72 (m,
1
11H), 5.19 (s, 1H), 4.95-4.96 (m, 1H), 3.51-3.53 (m, 1H), 1.44-
2.01 (m, 6H), 0.95-0.97 (m, 3H). 13C NMR: δ 154.2, 143.8, 131.5,
129.0 (2C), 128.8, 128.6, 128.5, 128.0 (2C), 126.9, 126.2, 123.1,
122.8, 119.0, 114.2, 81.6, 60.5, 54.4, 32.1, 29.6, 18.4, 14.1. MS
m/z (%): 329 (M+, 0.82), 313 (26), 232 (46), 231 (100), 202 (16).
Anal. Calcd for C23H23NO: C, 83.85; H, 7.04; N, 4.25. Found:
C, 83.89; H, 7.11; N, 4.31.
A Typical Procedure for the Preparation of 1-[(S)-
[(2S,6R)-2-Methyl-6-propylpiperidyl]phenylmethyl]-2-naph-
thalenol (6a). To a stirred solution of n-PrMgBr made from Mg
(365 mg, 15 mmol) and 1-bromopropane (1.84 g, 15 mmol) in
anhydrous Et2O (40 mL) was added dropwise a solution of 5 (494
mg, 1.5 mmol) in Et2O (15 mL) at -10 °C. Then a saturated
aqueous solution of NH4Cl (10 mL) was added to quench the
reaction and the separated organic layer was washed with H2O
and brine and dried over anhydrous Mg2SO4. Removal of the
solvent gave the crude product 6a (538 mg, 96%) as a yellowish
Acknowledgment. We are grateful to the National
Natural Science Foundation of China for financial
support.
Supporting Information Available: 1H NMR and 13C
NMR spectra of compounds 4, 5, and 7a-j‚HCl. This material
foamy solid, mp 102-103 °C; [R]25 +134.8 (c 0.2, CHCl3). IR:
D
ν 3447, 2961, 1525, 1447, 1231 cm-1; MS m/z (%): 372 (M+ - H,
0.28), 233 (24), 232 (85), 231 (100). Anal. Calcd for C26H31NO:
JO0480444
1900 J. Org. Chem., Vol. 70, No. 5, 2005